Elsevier

Neoplasia

Volume 13, Issue 7, July 2011, Pages 633-642, IN7-IN11
Neoplasia

Pigment Epithelium-Derived Factor Blocks Tumor Extravasation by Suppressing Amoeboid Morphology and Mesenchymal Proteolysis1,2

https://doi.org/10.1593/neo.11446Get rights and content
Under a Creative Commons license
open access

Abstract

Metastatic melanoma cells are highly adaptable to their in vivo microenvironment and can switch between protease-dependent mesenchymal and protease-independent amoeboid invasion to facilitate metastasis. Such adaptability can be visualized in vitro, when cells are cultured in conditions that recapitulate three-dimensional microenvironments. Using thick collagen layers in cell culture and in vivo extravasation assays, we found that pigment epithelium-derived factor (PEDF) suppressed lung extravasation of aggressive melanoma by coordinated regulation of cell shape and proteolysis. In cells grown on a thick collagen bed, PEDF overexpression and exogenous PEDF blocked the rapidly invasive, rounded morphology, and promoted an elongated, mesenchymal-like phenotype associated with reduced invasion. These changes in cell shape depended on decreased RhoA and increased Rac1 activation and were mediated by the up-regulation of Rac1-GEF, DOCK3 and down-regulation of Rac1-GAP, ARHGAP22. Surprisingly, we found that PEDF overexpression also blocked the trafficking of membrane-tethered, MT1-MMP to the cell surface through RhoA inhibition and Rac1 activation. In vivo, knockdown of Rac1 and DOCK3 or overexpression of MT1-MMP was sufficient to reverse the inhibitory effect of PEDF on extravasation. Using functional studies, we demonstrated that PEDF suppressed the rounded morphology and MT1-MMP surface localization through its antiangiongenic, 34-mer epitope and the recently identified PEDF receptor candidate, PNPLA2. Our findings unveil the coordinated regulation of cell shape and proteolysis and identify an unknown mechanism for PEDF's antimetastatic activity.

Abbreviations

PEDF
pigment epithelium-derived factor
MT1-MMP
membrane type-1 matrix metalloproteinase
PEDF-R
PNPLA2
LR
laminin receptor
AMT
amoeboid-to-mesenchymal transition

Cited by (0)

1

This work was supported by the National Institutes of Health (R01 HL68033 and R01HL077471 to O.V.) and the Ministerio de Ciencia e Innovación (SAF2007-6292 and SAF2010-19256 to B.J.). O.L. was supported by a National Institutes of Health/National Cancer Institute training grant (T32CA009560) and by the Malkin Scholars Program. J.L.O was supported by a Ministerio de Ciencia e Innovación fellowship and a SAF2007-62292 contract.

2

This article refers to supplementary materials, which are designated by Figures W1 to W11 and are available online at www.neoplasia.com.

3

Sánchez-Martinez shares first authorship.